Safety of immunotherapy post liver transplantation- A multicentered study of a prospective standardized clinical practice protocol
{{output}}
Background: Immune checkpoint-inhibitors (ICI) have improved cancer prognosis significantly, but their use has been avoided in liver transplant recipients (LTr) due to poorly characterized rejection risk. Data surrounding rejecti... ...
